Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 | SpringerLink
The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? - ScienceDirect
Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease - Eda Kaya, Yusuf Yilmaz, 2022
Life | Free Full-Text | FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic
The Association of Fibrosis-4 Index Scores with Severe Liver Outcomes in Primary Care | SpringerLink
Cureus | Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
IJMS | Free Full-Text | Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives
Why are non-invasive risk scores such as FIB-4 used in clinical practice? | Liver Fellow Network
Liverfy Journey ᐢ•ᴗ• on Twitter: "I finally found some time to work on liverfy 😑 Inspired by this tweet, I'm testing to code a #FIB4 calculator https://t.co/ylkFbS8UXZ" / Twitter
Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease | BMC Gastroenterology | Full Text
Formulas of HSI, FLI and FIB-4 indexes. | Download Scientific Diagram
Non-Alcoholic Fatty Liver Diagnosis - Viral Hepatitis and Liver Disease